Chance Leonard and R. Sean Churchill, MD, MBA, of Genesis Innovation Group and Capitan Orthopedics, discuss their SupraSpacer implant for treatment of massive irreparable rotator cuff tears in an interview with SmartTRAK.
This SmartTRAK interview features a panel of experts discussing the clinical shift in hip preservation toward pre-sutured, "off-the-shelf" allograft solutions.
Dr. Robert Spiro, CEO of Octane Biotherapeutics discusses the company’s progress to bring Novocart 3D and Novocart Inject to the US Cartilage Repair Market.
Stephania Bell, a licensed physical therapist, ESPN senior writer, and renowned sports injury analyst, brings together her clinical expertise and media experience, exploring how sports injuries in professional athletes intersect with those seen in the general population.
Gregory Berlet, MD, shares insights on trends in foot and ankle surgery, including MIS, ASCs, orthobiologics, and AI planning, in an interview with SmartTRAK.
Theradaptive’s Chief Scientific Officer Frank Vizesi provides an overview of the company’s unique protein and how it hopes to disrupt the bone replacement market in an interview with SmartTRAK at the 2025 NASS Biologic Interventions Meeting.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services.